Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
Bensinger
W I
WI
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Buckner
C D
CD
Rowley
S
S
Storb
R
R
Appelbaum
F R
FR
D018952:Antigens, CD34; D001782:Blood Donors; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology*; D006098:Granulocytes / Q000166:cytology; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology; D016176:T-Lymphocyte Subsets / Q000166:cytology; D014184:Transplantation, Homologous
D018952:Antigens, CD34; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor